# Prevention of Retained-Blood Outcomes With Active Clearance Technology

> **NCT02145858** · — · COMPLETED · sponsor: **ClearFlow, Inc.** · enrollment: 891 (actual)

## Conditions studied

- Hemorrhage
- Atrial Fibrillation, Postoperative

## Interventions

- **DEVICE:** Blood drainage post cardiac surgery using PleuraFlow System

## Key facts

- **NCT ID:** NCT02145858
- **Lead sponsor:** ClearFlow, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-07
- **Final completion:** 2016-11-30
- **Target enrollment:** 891 (ACTUAL)
- **Last updated:** 2018-05-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02145858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02145858, "Prevention of Retained-Blood Outcomes With Active Clearance Technology". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT02145858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*